|
|
hindbrain development
|
GO:0030902 |
3 |
0.897
|
|
|
|
regulation of wound healing
|
GO:0061041 |
56 |
0.855
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
109 |
0.846
|
|
|
|
maintenance of cell polarity
|
GO:0030011 |
2 |
0.816
|
|
|
|
establishment or maintenance of bipolar cell polarity
|
GO:0061245 |
2 |
0.735
|
|
|
|
embryonic retina morphogenesis in camera type eye
|
GO:0060059 |
1 |
0.707
|
|
|
|
hippo signaling
|
GO:0035329 |
20 |
0.695
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.689
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.659
|
|
|
|
embryonic morphogenesis
|
GO:0048598 |
85 |
0.633
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.633
|
|
|
|
neural tube formation
|
GO:0001841 |
3 |
0.631
|
|
|
|
establishment or maintenance of epithelial cell apical basal polarity
|
GO:0045197 |
1 |
0.614
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
4 |
0.609
|
|
|
|
action potential
|
GO:0001508 |
34 |
0.607
|
|
|
|
wound healing
|
GO:0042060 |
115 |
0.592
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
4 |
0.592
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.587
|
|
|
|
protein localization to adherens junction
|
GO:0071896 |
2 |
0.576
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
11 |
0.568
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.547
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.539
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
78 |
0.515
|
|
|
|
positive regulation of blood vessel endothelial cell migration
|
GO:0043536 |
16 |
0.500
|
|
|
|
mature dendritic cell differentiation
|
GO:0097029 |
2 |
0.499
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
132 |
0.498
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
39 |
0.497
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.478
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.469
|
|
|
|
cellular response to tumor necrosis factor
|
GO:0071356 |
63 |
0.465
|
|
|
|
heart morphogenesis
|
GO:0003007 |
48 |
0.417
|
|
|
|
schwann cell development
|
GO:0014044 |
1 |
0.417
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.411
|
|
|
|
positive regulation of nf kappab transcription factor activity
|
GO:0051092 |
81 |
0.409
|
|
|
|
establishment or maintenance of apical basal cell polarity
|
GO:0035088 |
2 |
0.409
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.408
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
64 |
0.397
|
|
|
|
endomembrane system organization
|
GO:0010256 |
196 |
0.395
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.394
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.381
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
135 |
0.378
|
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
86 |
0.375
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.365
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.364
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.357
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
101 |
0.348
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.347
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
2 |
0.345
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
177 |
0.332
|
|
|
|
negative regulation of wound healing
|
GO:0061045 |
25 |
0.322
|
|
|
|
regulation of eosinophil activation
|
GO:1902566 |
2 |
0.314
|
|
|
|
actin filament organization
|
GO:0007015 |
128 |
0.313
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
21 |
0.313
|
|
|
|
plasma membrane organization
|
GO:0007009 |
115 |
0.312
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.310
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.300
|
|
|
|
muscle organ morphogenesis
|
GO:0048644 |
19 |
0.291
|
|
|
|
neural tube development
|
GO:0021915 |
9 |
0.285
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.284
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
41 |
0.278
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.275
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.271
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
99 |
0.246
|
|
|
|
water homeostasis
|
GO:0030104 |
14 |
0.241
|
|
|
|
muscle organ development
|
GO:0007517 |
56 |
0.234
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.232
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.227
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.223
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
179 |
0.218
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
34 |
0.215
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.211
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.210
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
47 |
0.208
|
|
|
|
response to tumor necrosis factor
|
GO:0034612 |
76 |
0.203
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
19 |
0.202
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
18 |
0.201
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
42 |
0.195
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.194
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.192
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.191
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.190
|
|
|
|
keratinocyte proliferation
|
GO:0043616 |
17 |
0.187
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.183
|
|
|
|
protein localization to cell junction
|
GO:1902414 |
3 |
0.180
|
|
|
|
system process
|
GO:0003008 |
349 |
0.180
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.176
|
|
|
|
neuronal action potential
|
GO:0019228 |
9 |
0.170
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.169
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.169
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.168
|
|
|
|
calcium independent cell cell adhesion via plasma membrane cell adhesion molecules
|
GO:0016338 |
2 |
0.167
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.165
|
|
|
|
eye morphogenesis
|
GO:0048592 |
16 |
0.161
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
80 |
0.159
|
|
|
|
metanephric nephron epithelium development
|
GO:0072243 |
4 |
0.153
|
|
|
|
skin development
|
GO:0043588 |
76 |
0.149
|
|
|
|
cell adhesion
|
GO:0007155 |
325 |
0.149
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.145
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.143
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
85 |
0.142
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
147 |
0.141
|
|
|
|
glial cell development
|
GO:0021782 |
7 |
0.140
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
76 |
0.140
|
|
|
|
cell junction organization
|
GO:0034330 |
79 |
0.137
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.136
|
|
|
|
schwann cell differentiation
|
GO:0014037 |
1 |
0.136
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.134
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.134
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.133
|
|
|
|
negative regulation of cell matrix adhesion
|
GO:0001953 |
14 |
0.132
|
|
|
|
tumor necrosis factor mediated signaling pathway
|
GO:0033209 |
27 |
0.131
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.131
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.126
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
59 |
0.125
|
|
|
|
apical junction assembly
|
GO:0043297 |
19 |
0.124
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.123
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.122
|
|
|
|
cell cell junction organization
|
GO:0045216 |
69 |
0.122
|
|
|
|
negative regulation of response to external stimulus
|
GO:0032102 |
83 |
0.121
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.114
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.113
|
|
|
|
disruption by host of symbiont cells
|
GO:0051852 |
2 |
0.112
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.111
|
|
|
|
cell migration involved in gastrulation
|
GO:0042074 |
1 |
0.109
|
|
|
|
eosinophil activation
|
GO:0043307 |
3 |
0.105
|
|
|
|
tube morphogenesis
|
GO:0035239 |
95 |
0.105
|
|
|
|
sensory organ development
|
GO:0007423 |
52 |
0.105
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.104
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
141 |
0.104
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.103
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.102
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.101
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.100
|
|
|
|
myelination
|
GO:0042552 |
6 |
0.100
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.100
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.098
|
|
|
|
cell cell junction assembly
|
GO:0007043 |
25 |
0.095
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
166 |
0.094
|
|
|
|
positive regulation of neutrophil apoptotic process
|
GO:0033031 |
1 |
0.092
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
172 |
0.091
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.090
|
|
|
|
eye photoreceptor cell differentiation
|
GO:0001754 |
2 |
0.090
|
|
|
|
gtp metabolic process
|
GO:0046039 |
239 |
0.090
|
|
|
|
regulation of actin filament length
|
GO:0030832 |
56 |
0.090
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
168 |
0.087
|
|
|
|
morphogenesis of an epithelial sheet
|
GO:0002011 |
12 |
0.087
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.086
|
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
60 |
0.086
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
93 |
0.083
|
|
|
|
taxis
|
GO:0042330 |
157 |
0.082
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.082
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.082
|
|
|
|
camera type eye development
|
GO:0043010 |
25 |
0.082
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
180 |
0.082
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
56 |
0.081
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.081
|
|
|
|
regulation of small gtpase mediated signal transduction
|
GO:0051056 |
156 |
0.080
|
|
|
|
cation homeostasis
|
GO:0055080 |
189 |
0.079
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.079
|
|
|
|
blood vessel endothelial cell migration
|
GO:0043534 |
42 |
0.079
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.079
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.077
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
177 |
0.076
|
|
|
|
negative regulation of chemokine secretion
|
GO:0090198 |
1 |
0.076
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.076
|
|
|
|
regulation of actin polymerization or depolymerization
|
GO:0008064 |
56 |
0.075
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
101 |
0.074
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.073
|
|
|
|
blood circulation
|
GO:0008015 |
113 |
0.072
|
|
|
|
eye development
|
GO:0001654 |
42 |
0.072
|
|
|
|
cell differentiation involved in metanephros development
|
GO:0072202 |
3 |
0.071
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.070
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.069
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.068
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
31 |
0.067
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.067
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.067
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.065
|
|
|
|
tight junction assembly
|
GO:0070830 |
14 |
0.065
|
|
|
|
regulation of cell matrix adhesion
|
GO:0001952 |
42 |
0.064
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.064
|
|
|
|
tissue morphogenesis
|
GO:0048729 |
96 |
0.064
|
|
|
|
positive regulation of myeloid cell apoptotic process
|
GO:0033034 |
2 |
0.063
|
|
|
|
chemotaxis
|
GO:0006935 |
157 |
0.063
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.063
|
|
|
|
head development
|
GO:0060322 |
108 |
0.063
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.063
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
116 |
0.062
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.062
|
|
|
|
neural nucleus development
|
GO:0048857 |
47 |
0.061
|
|
|
|
response to growth factor
|
GO:0070848 |
205 |
0.061
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.061
|
|
|
|
regulation of neutrophil mediated killing of bacterium
|
GO:0070950 |
1 |
0.060
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.060
|
|
|
|
positive regulation of eosinophil degranulation
|
GO:0043311 |
1 |
0.059
|
|
|
|
eosinophil mediated immunity
|
GO:0002447 |
2 |
0.058
|
|
|
|
heart development
|
GO:0007507 |
95 |
0.058
|
|
|
|
negative regulation of cell substrate adhesion
|
GO:0010812 |
24 |
0.057
|
|
|
|
brain development
|
GO:0007420 |
97 |
0.057
|
|
|
|
eosinophil degranulation
|
GO:0043308 |
2 |
0.056
|
|
|
|
peripheral nervous system axon ensheathment
|
GO:0032292 |
1 |
0.056
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.056
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.056
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
9 |
0.055
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.055
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.055
|
|
|
|
regulation of endothelial cell migration
|
GO:0010594 |
67 |
0.054
|
|
|
|
embryonic organ development
|
GO:0048568 |
36 |
0.054
|
|
|
|
cell chemotaxis
|
GO:0060326 |
112 |
0.054
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
128 |
0.053
|
|
|
|
negative regulation of gliogenesis
|
GO:0014014 |
3 |
0.053
|
|
|
|
muscle tissue development
|
GO:0060537 |
62 |
0.053
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.053
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
122 |
0.052
|
|
|
|
neurotransmitter secretion
|
GO:0007269 |
4 |
0.052
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.052
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
149 |
0.052
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
15 |
0.052
|
|
|
|
negative regulation of hippo signaling
|
GO:0035331 |
6 |
0.051
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.051
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.051
|
|
|
|
regulation of glial cell proliferation
|
GO:0060251 |
4 |
0.051
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.051
|
|
|
|
regulation of myeloid leukocyte mediated immunity
|
GO:0002886 |
4 |
0.051
|
|
|
|
chordate embryonic development
|
GO:0043009 |
34 |
0.051
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.050
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.050
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.048
|
|
|
|
positive regulation of neutrophil mediated killing of bacterium
|
GO:0070962 |
1 |
0.048
|
|
|
|
regulation of neutrophil mediated killing of gram negative bacterium
|
GO:0070951 |
1 |
0.048
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.048
|
|
|
|
positive regulation of gliogenesis
|
GO:0014015 |
4 |
0.047
|
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.047
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.046
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
48 |
0.046
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.046
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.046
|
|
|
|
leukocyte migration
|
GO:0050900 |
107 |
0.046
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
41 |
0.046
|
|
|
|
positive regulation of endothelial cell migration
|
GO:0010595 |
39 |
0.046
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.046
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.045
|
|
|
|
positive regulation of glial cell proliferation
|
GO:0060252 |
2 |
0.044
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
82 |
0.044
|
|
|
|
circulatory system process
|
GO:0003013 |
113 |
0.044
|
|
|
|
negative regulation of protein transport
|
GO:0051224 |
75 |
0.043
|
|
|
|
cation transport
|
GO:0006812 |
331 |
0.042
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
17 |
0.041
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.041
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.041
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
104 |
0.041
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.041
|
|
|
|
gliogenesis
|
GO:0042063 |
21 |
0.040
|
|
|
|
neutrophil mediated killing of gram negative bacterium
|
GO:0070945 |
1 |
0.040
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.040
|
|
|
|
digestive system development
|
GO:0055123 |
75 |
0.040
|
|
|
|
negative regulation of transport
|
GO:0051051 |
176 |
0.039
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
6 |
0.039
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.039
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
91 |
0.039
|
|
|
|
gastrulation with mouth forming second
|
GO:0001702 |
1 |
0.039
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.039
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.038
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
156 |
0.038
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
152 |
0.038
|
|
|
|
positive regulation of rho protein signal transduction
|
GO:0035025 |
4 |
0.038
|
|
|
|
regulation of protein processing
|
GO:0070613 |
150 |
0.038
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
135 |
0.037
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.037
|
|
|
|
epithelium migration
|
GO:0090132 |
119 |
0.037
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.036
|
|
|
|
nephron tubule epithelial cell differentiation
|
GO:0072160 |
3 |
0.036
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
207 |
0.036
|
|
|
|
epithelial cell migration
|
GO:0010631 |
119 |
0.036
|
|
|
|
regulation of killing of cells of other organism
|
GO:0051709 |
4 |
0.035
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.035
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.035
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.035
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.035
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.034
|
|
|
|
neutrophil mediated immunity
|
GO:0002446 |
4 |
0.034
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.034
|
|
|
|
protein targeting to nucleus
|
GO:0044744 |
104 |
0.033
|
|
|
|
adenylate cyclase inhibiting g protein coupled receptor signaling pathway
|
GO:0007193 |
22 |
0.033
|
|
|
|
hemostasis
|
GO:0007599 |
76 |
0.033
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
132 |
0.033
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
24 |
0.033
|
|
|
|
dephosphorylation
|
GO:0016311 |
209 |
0.033
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
170 |
0.033
|
|
|
|
chemokine c c motif ligand 2 secretion
|
GO:0035926 |
1 |
0.033
|
|
|
|
embryo development ending in birth or egg hatching
|
GO:0009792 |
34 |
0.033
|
|
|
|
negative regulation of catabolic process
|
GO:0009895 |
104 |
0.032
|
|
|
|
regulation of hemostasis
|
GO:1900046 |
42 |
0.032
|
|
|
|
regulation of camp biosynthetic process
|
GO:0030817 |
45 |
0.032
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
239 |
0.032
|
|
|
|
glial cell differentiation
|
GO:0010001 |
11 |
0.032
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.032
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
60 |
0.032
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.032
|
|
|
|
regulation of nervous system development
|
GO:0051960 |
88 |
0.032
|
|
|
|
exocytosis
|
GO:0006887 |
71 |
0.032
|
|
|
|
positive regulation of cellular component movement
|
GO:0051272 |
181 |
0.032
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.032
|
|
|
|
actin filament based movement
|
GO:0030048 |
17 |
0.032
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
92 |
0.031
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.031
|
|
|
|
regulation of defense response
|
GO:0031347 |
154 |
0.031
|
|
|
|
release of cytoplasmic sequestered nf kappab
|
GO:0008588 |
4 |
0.031
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
244 |
0.031
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.031
|
|
|
|
regulation of cell activation
|
GO:0050865 |
125 |
0.030
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
55 |
0.030
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
74 |
0.030
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
157 |
0.030
|
|
|
|
protein import into nucleus
|
GO:0006606 |
104 |
0.030
|
|
|
|
myelin maintenance
|
GO:0043217 |
1 |
0.030
|
|
|
|
regulation of immune effector process
|
GO:0002697 |
91 |
0.030
|
|
|
|
positive regulation of toll like receptor 2 signaling pathway
|
GO:0034137 |
2 |
0.030
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.030
|
|
|
|
regulation of leukocyte chemotaxis
|
GO:0002688 |
46 |
0.030
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.029
|
|
|
|
neutrophil apoptotic process
|
GO:0001781 |
2 |
0.029
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.029
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.029
|
|
|
|
stem cell division
|
GO:0017145 |
2 |
0.029
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
156 |
0.029
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
84 |
0.029
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.029
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.028
|
|
|
|
positive regulation of response to external stimulus
|
GO:0032103 |
88 |
0.028
|
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.028
|
|
|
|
protein import
|
GO:0017038 |
130 |
0.028
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.028
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.028
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.028
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.028
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.028
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.027
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.027
|
|
|
|
myelination in peripheral nervous system
|
GO:0022011 |
1 |
0.027
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
142 |
0.027
|
|
|
|
anterior posterior axis specification embryo
|
GO:0008595 |
2 |
0.027
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.027
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.027
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.027
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
109 |
0.027
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.026
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.026
|
|
|
|
cellular cation homeostasis
|
GO:0030003 |
163 |
0.026
|
|
|
|
defense response to bacterium
|
GO:0042742 |
63 |
0.026
|
|
|
|
epithelial tube formation
|
GO:0072175 |
5 |
0.026
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.026
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.026
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
155 |
0.026
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
3 |
0.026
|
|
|
|
toll like receptor 2 signaling pathway
|
GO:0034134 |
4 |
0.026
|
|
|
|
negative regulation of vascular permeability
|
GO:0043116 |
7 |
0.025
|
|
|
|
granulocyte migration
|
GO:0097530 |
40 |
0.025
|
|
|
|
response to virus
|
GO:0009615 |
126 |
0.025
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.025
|
|
|
|
wound healing involved in inflammatory response
|
GO:0002246 |
2 |
0.025
|
|
|
|
memory
|
GO:0007613 |
3 |
0.025
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
209 |
0.025
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.025
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
3 |
0.024
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
124 |
0.024
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.024
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.024
|
|
|
|
tissue migration
|
GO:0090130 |
119 |
0.024
|
|
|
|
positive regulation of mesenchymal cell proliferation
|
GO:0002053 |
2 |
0.024
|
|
|
|
interleukin 1 secretion
|
GO:0050701 |
18 |
0.024
|
|
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
162 |
0.024
|
|
|
|
killing by host of symbiont cells
|
GO:0051873 |
2 |
0.024
|
|
|
|
positive regulation of superoxide anion generation
|
GO:0032930 |
4 |
0.024
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
59 |
0.024
|
|
|
|
axon ensheathment
|
GO:0008366 |
6 |
0.024
|
|
|
|
oocyte differentiation
|
GO:0009994 |
2 |
0.024
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
98 |
0.024
|
|
|
|
cell fate determination
|
GO:0001709 |
3 |
0.024
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
170 |
0.024
|
|
|
|
positive regulation of cytokine secretion involved in immune response
|
GO:0002741 |
2 |
0.023
|
|
|
|
disruption of cells of other organism involved in symbiotic interaction
|
GO:0051818 |
3 |
0.023
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
136 |
0.023
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
88 |
0.023
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
84 |
0.023
|
|
|
|
behavior
|
GO:0007610 |
112 |
0.023
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
117 |
0.023
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.023
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.023
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
83 |
0.023
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
117 |
0.023
|
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.022
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.022
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
190 |
0.022
|
|
|
|
neutrophil mediated killing of bacterium
|
GO:0070944 |
1 |
0.022
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
43 |
0.022
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.022
|
|
|
|
positive regulation of leukocyte degranulation
|
GO:0043302 |
3 |
0.022
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
82 |
0.022
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.022
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
185 |
0.022
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.022
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
180 |
0.022
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
61 |
0.021
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.021
|
|
|
|
positive regulation of myeloid leukocyte mediated immunity
|
GO:0002888 |
1 |
0.021
|
|
|
|
endothelial cell migration
|
GO:0043542 |
86 |
0.021
|
|
|
|
metal ion transport
|
GO:0030001 |
272 |
0.021
|
|
|
|
regulation of behavior
|
GO:0050795 |
82 |
0.021
|
|
|
|
positive regulation of immune response
|
GO:0050778 |
159 |
0.021
|
|
|
|
regulation of phagocytosis engulfment
|
GO:0060099 |
2 |
0.021
|
|
|
|
defense response to other organism
|
GO:0098542 |
129 |
0.021
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
79 |
0.021
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
24 |
0.021
|
|
|
|
regulation of stem cell maintenance
|
GO:2000036 |
4 |
0.021
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
128 |
0.021
|
|
|
|
establishment of cell polarity
|
GO:0030010 |
22 |
0.021
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
231 |
0.021
|
|
|
|
cellular homeostasis
|
GO:0019725 |
196 |
0.020
|
|
|
|
endothelial cell proliferation
|
GO:0001935 |
65 |
0.020
|
|
|
|
activation of innate immune response
|
GO:0002218 |
55 |
0.020
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
185 |
0.020
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
57 |
0.020
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
84 |
0.020
|
|
|
|
eosinophil activation involved in immune response
|
GO:0002278 |
2 |
0.020
|
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
83 |
0.020
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.020
|
|
|
|
phototransduction
|
GO:0007602 |
3 |
0.020
|
|
|
|
tripartite regional subdivision
|
GO:0007351 |
2 |
0.020
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
4 |
0.020
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.020
|
|
|
|
tube formation
|
GO:0035148 |
10 |
0.020
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.020
|
|
|
|
regulation of calcium ion transport into cytosol
|
GO:0010522 |
33 |
0.020
|
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.020
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
97 |
0.020
|
|
|
|
digestive tract development
|
GO:0048565 |
75 |
0.020
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.020
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
41 |
0.020
|
|
|
|
organ formation
|
GO:0048645 |
3 |
0.019
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
156 |
0.019
|
|
|
|
inflammatory response
|
GO:0006954 |
79 |
0.019
|
|
|
|
regulation of camp metabolic process
|
GO:0030814 |
52 |
0.019
|
|
|
|
macromolecular complex disassembly
|
GO:0032984 |
60 |
0.019
|
|
|
|
leukocyte activation
|
GO:0045321 |
164 |
0.019
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
39 |
0.019
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
44 |
0.019
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
146 |
0.019
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.019
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
97 |
0.019
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
121 |
0.019
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
82 |
0.019
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
121 |
0.019
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
90 |
0.019
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
86 |
0.019
|
|
|
|
negative regulation of sequestering of calcium ion
|
GO:0051283 |
41 |
0.018
|
|
|
|
regulation of response to biotic stimulus
|
GO:0002831 |
55 |
0.018
|
|
|
|
regulation of exocytosis
|
GO:0017157 |
46 |
0.018
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.018
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
79 |
0.018
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
125 |
0.018
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
87 |
0.018
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.018
|
|
|
|
activation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0006919 |
49 |
0.018
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.018
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
88 |
0.018
|
|
|
|
regulation of neutrophil apoptotic process
|
GO:0033029 |
1 |
0.018
|
|
|
|
convergent extension
|
GO:0060026 |
1 |
0.018
|
|
|
|
regulation of vascular permeability
|
GO:0043114 |
11 |
0.018
|
|
|
|
cytokine production
|
GO:0001816 |
247 |
0.018
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
82 |
0.018
|
|
|
|
endothelial cell development
|
GO:0001885 |
18 |
0.018
|
|
|
|
spermatid development
|
GO:0007286 |
4 |
0.018
|
|
|
|
response to estrogen
|
GO:0043627 |
47 |
0.018
|
|
|
|
positive regulation of eosinophil activation
|
GO:1902568 |
1 |
0.018
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
0.018
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
109 |
0.018
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
127 |
0.018
|
|
|
|
modification of morphology or physiology of other organism
|
GO:0035821 |
43 |
0.018
|
|
|
|
regulation of heart growth
|
GO:0060420 |
4 |
0.018
|
|
|
|
regulation of protein depolymerization
|
GO:1901879 |
22 |
0.018
|
|
